(R)-tert-Butyl 3-hydroxypiperidine-1-carboxylate

Product Overview

(R)-tert-Butyl 3-hydroxypiperidine-1-carboxylate represents a critical chiral intermediate utilized extensively in the modern pharmaceutical industry. This sophisticated organic compound features a protected piperidine ring structure, offering exceptional stability during complex synthetic sequences. The presence of the tert-butoxycarbonyl (Boc) protecting group ensures selective reactivity, allowing chemists to manipulate the hydroxyl functionality without compromising the amine center. Our manufacturing process guarantees high stereochemical purity, which is paramount for the efficacy of downstream active pharmaceutical ingredients.

As a key building block, this material supports the production of advanced therapeutic molecules. The rigorous control over the (R)-enantiomer configuration distinguishes our product from racemic mixtures, providing superior performance in asymmetric synthesis. We adhere to strict international standards to deliver consistency across every batch, facilitating seamless integration into your research and development pipelines. The stability of the Boc group under various conditions allows for versatile deprotection strategies, making it a preferred choice for process chemists.

Technical Specifications

Industrial Applications

This compound serves as a vital precursor in the synthesis of kinase inhibitors, most notably contributing to the manufacturing pathway of Ibrutinib. The structural integrity of the piperidine ring is essential for maintaining the biological activity of the final drug product. Beyond oncology applications, this intermediate finds utility in various medicinal chemistry projects requiring protected amino alcohol motifs. Its solubility profile and reactivity make it suitable for diverse coupling reactions and functional group transformations.

Research teams value this material for its reliability in scale-up processes. Whether used in early-stage drug discovery or late-stage commercial production, the consistent quality reduces the risk of synthesis failures. We support global pharmaceutical companies with a supply chain designed to meet fluctuating demand without compromising on purity standards. Our logistics network ensures that materials arrive in optimal condition, ready for immediate use in sensitive reactions.

Quality Assurance and Packaging

Quality is the cornerstone of our operation. Every batch undergoes comprehensive analysis using high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy. We provide a detailed Certificate of Analysis (COA) with each shipment, documenting all critical quality attributes. Our facilities operate under stringent safety protocols to prevent contamination and ensure product stability throughout the shelf life.

• Standard packaging includes 25 kg drums lined with protective materials to prevent moisture ingress.
• Custom packaging solutions are available to suit specific logistical requirements and client preferences.
• Storage recommendations include keeping the product in a cool, ventilated environment away from direct sunlight.
• Global shipping capabilities ensure timely delivery to major pharmaceutical hubs across continents.

Partner with us for a reliable source of high-performance chemical intermediates. Our technical team is ready to assist with specification inquiries and supply chain optimization. We are committed to sustainability and efficient waste management in our production processes. Contact us today to discuss your project needs and request a competitive bulk price quote for your upcoming synthesis campaigns.